OPRX - オプティマイザ―Rx (OptimizeRx Corporation)

OPRXのニュース

   OptimizeRx extends reach with Cooler Screens Partnership  2022/07/26 12:16:18 Seeking Alpha
OptimizeRx (OPRX) has announced a partnership with Cooler Screens, a media and merchandising platform that brings the best aspects of in-store digital advertising into the…
   With -3.8% Distance From Low, Is OptimizeRx Corporation (NASDAQ:OPRX) Poised For More Gains?  2022/07/23 16:00:00 Marketing Sentinel
In last trading session, OptimizeRx Corporation (NASDAQ:OPRX) saw 0.7 million shares changing hands with its beta currently measuring 0.86. Company’s recent per share price level of $20.55 trading at -$3.81 or -15.64% at ring of the bell on the day assigns it a market valuation of $355.10M. That closing price of OPRX’s stock is at … With -3.8% Distance From Low, Is OptimizeRx Corporation (NASDAQ:OPRX) Poised For More Gains? Read More »
   SVB Leerink Sees ''Cheaper Way'' To Pharma Digital Marketing With This Stock  2022/07/15 19:10:54 Benzinga
SVB Leerink initiated coverage on OptimizeRx Corporation (NASDAQ: OPRX ) with a buy rating and a price target of $38, implying an upside of 36%. The analysts say OptimizeRx is the largest EHR-embedded messaging network and enjoys a solid financial profile of 30%+ top-line growth and mid-teens adjusted EBITDA margins. Despite this, the valuation is cheap. The stock currently trades at an ~2.5 turn discount to pharma digital … Full story available on Benzinga.com
   OptimizeRx: Small-Cap Stock With Potential Upside (NASDAQ:OPRX)  2022/06/27 10:31:02 Seeking Alpha
OptimizeRx has strong network of large customers with a competitive advantage. Click here to see OPRX''s growth catalysts, risks, and my PT for OPRX stock.
   OptimizeRx (OPRX) Investor Presentation - Slideshow (NASDAQ:OPRX)  2022/06/26 11:04:15 Seeking Alpha
The following slide deck was published by OptimizeRx Corporation in conjunction with this event.
   OptimizeRx Completes Platform Integration of TelaRep One-Click Prescriber Connectivity Solution  2022/06/07 12:00:00 Wallstreet:Online
- Launched in April 2020, TelaRep allows doctors to text pharmaceutical representatives directly from within the electronic health record (EHR) platform - As part of OptimizeRx’s Therapy, Initiation and Persistence Platform, TelaRep is now being used by over 200,000 in-network healthcare providers (HCPs) ROCHESTER, Mich., June 07, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq:
   OptimizeRx Completes Platform Integration of TelaRep™ One-Click Prescriber Connectivity Solution  2022/06/07 12:00:00 GlobeNewswire
- Launched in April 2020, TelaRep allows doctors to text pharmaceutical representatives directly from within the electronic health record (EHR) platform
   OptimizeRx authorizes $20M share repurchase program  2022/05/17 13:26:37 Seeking Alpha
OptimizeRx (OPRX) has announced that its Board of Directors has unanimously authorized a share repurchase program, under which OptimizeRx may repurchase up to $20M of its…
   OptimizeRx Corporation (OPRX) CEO William Febbo on Q1 2022 Results - Earnings Call Transcript  2022/05/05 02:42:10 Seeking Alpha
OptimizeRx Corporation (NASDAQ:NASDAQ:OPRX) Q1 2022 Earnings Conference Call May 04, 2022, 04:30 PM ET Company Participants William Febbo - Chief Executive Officer Ed Stelmakh - Chief…
   OptimizeRx Non-GAAP EPS of -$0.01 in-line, revenue of $13.73M beats by $0.18M  2022/05/04 20:44:25 Seeking Alpha
OptimizeRx press release (OPRX): Q1 Non-GAAP EPS of -$0.01 in-line.Revenue of $13.73M (+22.3% Y/Y) beats by $0.18M.Outlook: The Company is reaffirming its full year financial outlook…
   OptimizeRx Co. (NASDAQ:OPRX) Insider Sells $726,533.67 in Stock  2021/12/24 10:08:42 ETF Daily News
OptimizeRx Co. (NASDAQ:OPRX) insider Stephen L. Silvestro sold 13,241 shares of the companys stock in a transaction dated Friday, December 17th. The stock was sold at an average price of $54.87, for a total transaction of $726,533.67. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed [] The post OptimizeRx Co. (NASDAQ:OPRX) Insider Sells $726,533.67 in Stock appeared first on ETF Daily News .
   OptimizeRx CEO Issues Open Letter to Shareholders Detailing the Completion of Internal Management Changes  2021/12/22 13:00:00 Intrado Digital Media
ROCHESTER, Mich., Dec. 22, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the Company) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today issued an open letter from the CEO to shareholders detailing the completion of internal management changes. The full letter is published below:
   Contrasting Capita (OTCMKTS:CTAGY) and OptimizeRx (NASDAQ:OPRX)  2021/12/18 09:34:45 Dakota Financial News
Capita (OTCMKTS:CTAGY) and OptimizeRx (NASDAQ:OPRX) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Volatility and Risk Capita has a beta of 1.02, meaning that its stock price is 2% []
   OptimizeRx (NASDAQ:OPRX) Shares Gap Down to $55.43  2021/12/15 16:44:41 Transcript Daily
OptimizeRx Co. (NASDAQ:OPRX)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $55.43, but opened at $53.87. OptimizeRx shares last traded at $54.97, with a volume of 7 shares trading hands. A number of research analysts have issued reports on OPRX shares. Royal Bank of Canada upped their […]
   OptimizeRx Co. (NASDAQ:OPRX) Receives Average Rating of “Buy” from Brokerages  2021/12/13 23:32:42 Dakota Financial News
OptimizeRx Co. (NASDAQ:OPRX) has been assigned an average rating of “Buy” from the seven ratings firms that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation and five have given a buy recommendation to the company. The average twelve-month target price among brokerages that have covered […]

calendar